RxDoctor Payments Data

Esther Ogunjimi, MD

Obstetrics & Gynecology · Lubbock, TXNPI 1013229871

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intuitive Surgical at 49.6% of the total. Reporting peaked in 2022 at $8,549 and has fallen 84.8% since, to $1,303 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,919in general payments, 2019–2025

Across 45 payments — averaging $553.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$12K
  • BD$12K
  • Astellas Pharma US Inc$238
  • Coopersurgical, Inc.$120
  • Baxter Healthcare$94
  • Bayer$52
  • plus $111 from 4 others

What the payments were for

  • Consulting fees$11,08444%
  • Travel & lodging$3,29213%
  • Food & beverage$9304%
  • Education$6,61327%
  • Other$3,00012%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,919 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Medicare billing

Part B allowed, 2024
$2,456
Medicare patients
22
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibandronate Sodium12$332
Estradiol17$326

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Lubbock

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →